Korea Investment CORP Has $53.57 Million Stock Holdings in Corteva, Inc. $CTVA

Key Points

• Korea Investment CORP increased its position in Corteva by 32.3% to 792,095 shares worth $53.57 million, representing about 0.12% of the company while institutional investors hold 81.54% of the stock.
• Analysts have a consensus rating of Moderate Buy with a $82.80 price target, and several firms (Argus, RBC, BofA, CICC) recently upgraded or raised their targets on Corteva.
• Corteva's latest quarter saw EPS meet expectations at $0.22 but revenue miss estimates ($3.91B vs. $4.23B); the company set FY2026 guidance of 3.45–3.70 EPS and announced a $0.18 quarterly dividend (0.9% yield).

Korea Investment CORP lifted its position in shares of Corteva, Inc. (NYSE:CTVA - Free Report) by 32.3% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 792,095 shares of the company's stock after purchasing an additional 193,306 shares during the quarter. Korea Investment CORP owned 0.12% of Corteva worth $53,569,000 at the end of the most recent reporting period.

Other large investors have also made changes to their positions in the company. Brighton Jones LLC lifted its holdings in Corteva by 307.2% during the fourth quarter. Brighton Jones LLC now owns 15,588 shares of the company's stock worth $888,000 after acquiring an additional 11,760 shares in the last quarter. Woodline Partners LP increased its holdings in shares of Corteva by 40.3% in the first quarter. Woodline Partners LP now owns 57,919 shares of the company's stock worth $3,645,000 after acquiring an additional 16,644 shares in the last quarter. Golden State Wealth Management LLC increased its holdings in shares of Corteva by 113.8% in the second quarter. Golden State Wealth Management LLC now owns 1,251 shares of the company's stock worth $93,000 after acquiring an additional 666 shares in the last quarter. Savant Capital LLC raised its position in shares of Corteva by 20.7% during the second quarter. Savant Capital LLC now owns 20,711 shares of the company's stock worth $1,544,000 after purchasing an additional 3,548 shares during the period. Finally, Wedbush Securities Inc. lifted its holdings in shares of Corteva by 11.7% during the 2nd quarter. Wedbush Securities Inc. now owns 5,253 shares of the company's stock valued at $391,000 after purchasing an additional 549 shares in the last quarter. Institutional investors own 81.54% of the company's stock.

Wall Street Analyst Weigh In

Several equities analysts recently issued reports on CTVA shares. Argus upgraded Corteva to a "strong-buy" rating in a research report on Friday, January 16th. CICC Research upped their price target on shares of Corteva from $70.00 to $80.00 and gave the company an "outperform" rating in a report on Wednesday, February 11th. Wall Street Zen downgraded shares of Corteva from a "buy" rating to a "hold" rating in a research report on Saturday, February 7th. Royal Bank Of Canada boosted their price objective on shares of Corteva from $80.00 to $89.00 and gave the company an "outperform" rating in a research report on Thursday, February 5th. Finally, Bank of America increased their target price on Corteva from $80.00 to $82.00 and gave the stock a "buy" rating in a report on Thursday, January 8th. One research analyst has rated the stock with a Strong Buy rating, thirteen have issued a Buy rating and eight have issued a Hold rating to the company's stock. Based on data from MarketBeat, Corteva has a consensus rating of "Moderate Buy" and a consensus price target of $82.80.

Corteva Trading Up 0.5%

Shares of NYSE:CTVA opened at $76.95 on Monday. Corteva, Inc. has a 52-week low of $53.40 and a 52-week high of $80.90. The company has a debt-to-equity ratio of 0.07, a quick ratio of 0.96 and a current ratio of 1.43. The company has a market capitalization of $51.75 billion, a P/E ratio of 48.70, a price-to-earnings-growth ratio of 2.63 and a beta of 0.72. The company has a 50-day simple moving average of $73.00 and a 200 day simple moving average of $69.00.

Corteva (NYSE:CTVA - Get Free Report) last issued its earnings results on Tuesday, February 3rd. The company reported $0.22 EPS for the quarter, hitting the consensus estimate of $0.22. The company had revenue of $3.91 billion during the quarter, compared to the consensus estimate of $4.23 billion. Corteva had a return on equity of 9.06% and a net margin of 6.29%.The firm's revenue for the quarter was down 1.7% compared to the same quarter last year. During the same period in the previous year, the company posted $0.32 EPS. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. Sell-side analysts forecast that Corteva, Inc. will post 2.96 earnings per share for the current year.

Corteva Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Monday, March 16th. Shareholders of record on Monday, March 2nd will be given a dividend of $0.18 per share. This represents a $0.72 dividend on an annualized basis and a yield of 0.9%. The ex-dividend date of this dividend is Monday, March 2nd. Corteva's payout ratio is 45.57%.

Insider Activity at Corteva

In other Corteva news, insider Brian Titus sold 8,311 shares of the company's stock in a transaction on Friday, February 20th. The shares were sold at an average price of $76.55, for a total value of $636,207.05. Following the transaction, the insider directly owned 8,090 shares in the company, valued at $619,289.50. The trade was a 50.67% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. 0.15% of the stock is currently owned by corporate insiders.

About Corteva

Corteva, Inc NYSE: CTVA is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva's operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.

Want to see what other hedge funds are holding CTVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Corteva, Inc. (NYSE:CTVA - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.